相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial
Barbara H. McGovern et al.
CLINICAL INFECTIOUS DISEASES (2021)
RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients' Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections
Sahil Khanna et al.
CLINICAL INFECTIOUS DISEASES (2021)
In vivo commensal control of Clostridioides difficile virulence
Brintha P. Girinathan et al.
CELL HOST & MICROBE (2021)
Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
Charmaine Normington et al.
NPJ BIOFILMS AND MICROBIOMES (2021)
C. difficile exploits a host metabolite produced during toxin-mediated disease
Kali M. Pruss et al.
NATURE (2021)
Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer
Melinda A. Engevik et al.
ACS INFECTIOUS DISEASES (2021)
Bile salt metabolism is not the only factor contributing to Clostridioides (Clostridium) difficile disease severity in the murine model of disease
Caitlin A. Jukes et al.
GUT MICROBES (2020)
The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Current Understanding and Gap Analysis
Mark H. Wilcox et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Clostridioides difficile proline fermentation in response to commensal clostridia
Christopher A. Lopez et al.
ANAEROBE (2020)
Clostridioides difficile Senses and Hijacks Host Heme for Incorporation into an Oxidative Stress Defense System
Reece J. Knippel et al.
CELL HOST & MICROBE (2020)
An ecological framework to understand the efficacy of fecal microbiota transplantation
Yandong Xiao et al.
NATURE COMMUNICATIONS (2020)
Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization
Fatima C. Pereira et al.
NATURE COMMUNICATIONS (2020)
Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis
Raseen Tariq et al.
CLINICAL INFECTIOUS DISEASES (2019)
The gut microbiome in obesity
Ching-Hung Tseng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon
C. M. Rooney et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
Jessica R. Allegretti et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
The effect of antibiotics on the composition of the intestinal microbiota - a systematic review
Petra Zimmermann et al.
JOURNAL OF INFECTION (2019)
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2018)
Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis
Kathryn L. Nawrocki et al.
ENVIRONMENTAL MICROBIOLOGY (2018)
Role of the gut microbiota in nutrition and health
Ana M. Valdes et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Role of the gut microbiota in nutrition and health
Ana M. Valdes et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Protective Effects of Bifidobacterial Strains Against Toxigenic Clostridium difficile
Yanxia Wei et al.
FRONTIERS IN MICROBIOLOGY (2018)
Metabolic Reprogramming of Clostridioides difficile During the Stationary Phase With the Induction of Toxin Production
Julia D. Hofmann et al.
FRONTIERS IN MICROBIOLOGY (2018)
Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection
Yafet Mamo et al.
CLINICAL INFECTIOUS DISEASES (2018)
A human gut ecosystem protects against C. difficile disease by targeting TcdA
Sarah Lynn Martz et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection
Caroline Sheitoyan-Pesant et al.
CLINICAL INFECTIOUS DISEASES (2016)
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
Sahil Khanna et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates
L. Valdes-Varela et al.
FRONTIERS IN MICROBIOLOGY (2016)
Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line
J. M. Aguado et al.
JOURNAL OF HOSPITAL INFECTION (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Charlie G. Buffie et al.
NATURE (2015)
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
Filipe De Vadder et al.
CELL (2014)
Gut Microbiota-Produced Succinate Promotes C-difficile Infection after Antibiotic Treatment or Motility Disturbance
Jessica A. Ferreyra et al.
CELL HOST & MICROBE (2014)
Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis
Claudia Slimings et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Adaptive Strategies and Pathogenesis of Clostridium difficile from In Vivo Transcriptomics
Claire Janoir et al.
INFECTION AND IMMUNITY (2013)
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Katharine M. Ng et al.
NATURE (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut
Elaine O. Petrof et al.
MICROBIOME (2013)
Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins
Paula Carasi et al.
ANAEROBE (2012)
Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
Trevor D. Lawley et al.
PLOS PATHOGENS (2012)
The role of gut microbiota in immune homeostasis and autoimmunity
Hsin-Jung Wu et al.
GUT MICROBES (2012)
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Koji Atarashi et al.
SCIENCE (2011)
Inflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced IκBα Expression and NF-κB Inactivation
Lesley E. Smythies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Lactobacillus delbrueckii ssp bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells
Pratik Banerjee et al.
GUT PATHOGENS (2009)
分享论文
